Results 261 to 270 of about 143,069 (349)

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source

803 Study of Coagulation Factors in Patients with Mild Prolongation of Prothrombin Time: Implications for Neurosurgical Patients

open access: bronze, 2004
Samuel Barnett   +5 more
openalex   +1 more source

Determination of Fibrinogen Ratio Cutoff Limits Using Indirect Reference Interval Methodology

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction Discordant fibrinogen antigen to activity ratios are utilized by clinicians as evidence of dysfibrinogenemia. Abnormal ratio cutoffs implemented by clinical laboratories are typically determined by validation studies that include limited numbers of samples.
Abdulrahman Saadalla   +3 more
wiley   +1 more source

Common Hematologic Emergencies—Acute Promyelocytic Leukemia and Microangiopathic Hemolytic Anemias—A Pivotal Role of Clinical Laboratory

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Hematologic emergencies are urgent health conditions which result in significant mortality and morbidity unless timely therapeutic measures are taken. Therapeutic success depends on their timely and accurate recognition by hematology laboratory services.
Ganna Shestakova   +2 more
wiley   +1 more source

Proteolytic enzyme systems [PDF]

open access: yes, 1993
Fritz, Hans   +4 more
core   +1 more source

Effect of Heparin on the Prothrombin Time.

open access: yesAnesthesia & Analgesia, 1947
Margaret Hurn   +2 more
openaire   +4 more sources

Diagnostic Performance of Prothrombin Time and Activated Partial Thromboplastin Time in Children: A Service Evaluation

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Background Coagulation screening, consisting of prothrombin time (PT) and activated partial prothrombin time (aPTT), is routinely performed in paediatrics to identify bleeding disorders or guide peri‐procedural management. We evaluated the trends in utilisation and diagnostic yield of PT and aPTT testing as part of coagulation screening in a ...
Gerard Gurumurthy   +4 more
wiley   +1 more source

Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV‐Related Cirrhosis: A Landmark Analysis

open access: yesJournal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aims The use of aspirin in hepatocellular carcinoma (HCC) prevention and the risk of gastrointestinal (GI) bleeding is still uncertain in patients with hepatitis B virus (HBV)‐related cirrhosis. We investigated the association between aspirin use and the risks of HCC and GI bleeding in patients with HBV‐related cirrhosis ...
Mi Na Kim   +9 more
wiley   +1 more source

Polymethyl Methacrylate-Based Smart Microfluidic Point-of-Care Testing of Prothrombin Time and International Normalized Ratio through Optical Detection.

open access: yesComput Math Methods Med, 2022
Abdulhay EW   +8 more
europepmc   +1 more source

The long‐term outcome and changes in tricuspid regurgitation pressure gradient in dogs diagnosed with pulmonary hypertension and Angiostrongylus vasorum infestation

open access: yesJournal of Small Animal Practice, EarlyView.
Objectives Angiostrongylus vasorum (AV) is a metastrongylid parasite that has been associated with pulmonary hypertension (PH) in dogs. The objectives of the study were to describe the clinical presentation of dogs with AV and PH, document changes in tricuspid regurgitation maximum pressure gradient (TR Max PG) in subsequent months and years, record ...
R. Turner   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy